Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
18 /100
LOW RISK
Score updated Aug 28, 2026

ORMP — Oramed Pharmaceuticals Inc. Dilution Risk Tracker

Track ORMP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ORMP — Get alerts when the score changes →

As of August 28, 2026, Oramed Pharmaceuticals Inc. (ORMP) has a DilutionWatch DilutionScore of 18/100, rated LOW dilution risk. Oramed Pharmaceuticals Inc. has a market capitalization of $162.48M, 41.60M shares outstanding, 72 institutional holders tracked. Stored dilution-related fields include 20.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ORMP.
🔔 Track ORMP — Get forecast alerts →

Market Data

Market Cap$162.48M
Shares Outstanding41.60M
Float28.57M
Cash$72.70M
Debt$106.58M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 26.1% shares (2026Q1 vs prior)
72 institutional holders · 1.18M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 528.1K shares
#2 ARMISTICE CAPITAL, LLC 297.7K shares
#3 BlackRock, Inc. 102.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest835.5K
Days to Cover5.7
% of Float2.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2013-08-31
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-31
8-K 8K EVENT 2026-03-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ORMP Dilution Snapshot

Oramed Pharmaceuticals Inc. (ORMP) has a DilutionScore of 18/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ORMP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ORMP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ORMP
ORMP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.